Analyst Expectations For Amgen's Future

分析师对安进未来的预期

Benzinga · 01/02 20:00

Amgen (NASDAQ:AMGN) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish.

安进（纳斯达克：AMGN）在上个季度接受了11位分析师的分析，显示出从看好到看淡的多种观点。

The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.

下表提供了他们近期评级的快速概览，突显出过去30天情绪的变化，并将其与之前几个月进行比较。

The 12-month price targets, analyzed by analysts, offer insights with an average target of $341.18, a high estimate of $405.00, and a low estimate of $256.00. A decline of 3.38% from the prior average price target is evident in the current average.

经过分析师分析的12个月价格目标提供了见解，平均目标为341.18美元，高估计为405.00美元，低估计为256.00美元。当前平均价格目标明显比之前的平均价格目标下降了3.38%。

Decoding Analyst Ratings: A Detailed Look

In examining recent analyst actions, we gain insights into how...

在审视近期分析师的行...

登录免费看全文

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。更多信息

Analyst Expectations For Amgen's Future

Analyst Expectations For Amgen's Future

风险及免责提示

声明